DE OLIVEIRA ET AL.: "A CD 19/Fc fusion protein for detection of anti- CD 19 chimeric antigen receptors", JOURNAL OF TRANSLATIONAL MEDICINE, vol. 11, 29 January 2013 (2013-01-29), pages 1 - 9, XP021146986 (C0)

J. N. KOCHENDERFER ET AL: "B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells", BLOOD, vol. 119, no. 12, 8 December 2011 (2011-12-08), pages 2709 - 2720, XP055145503, ISSN: 0006-4971, DOI: 10.1182/blood-2011-10-384388 (C0)

JAE H. PARK ET AL: "CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date", BLOOD, vol. 127, no. 26, 20 May 2016 (2016-05-20), pages 3312 - 3320, XP055449358, ISSN: 0006-4971, DOI: 10.1182/blood-2016-02-629063 (C0)

JENA ET AL.: "Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD 19-Specific T Cells in Clinical Trials", PLOS ONE, vol. 8, no. 3, 1 March 2013 (2013-03-01), pages 1 - 12, XP055122892 (C0)

KAWALEKAR ET AL.: "Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells", IMMUNITY, vol. 44, 16 February 2016 (2016-02-16), pages 380 - 390, XP029428484 (C0)

KIEBACK ET AL.: "A safeguard eliminates T cell receptor gene -modified autoreactive T cells after adoptive transfer", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 105, no. 2, 15 January 2008 (2008-01-15), pages 623 - 628, XP002550365 (C0)

ZHENG ET AL.: "Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry", JOURNAL OF TRANSLATIONAL MEDICINE, vol. 10, 13 February 2012 (2012-02-13), pages 1 - 6, XP021118752 (C0)

WO-A1-2014/190273 (C0)

WO-A2-2008/133722 (C0)

WO-A2-2012/149356 (C0)

WO-A2-2018/023100 (C0)

YANLING WU ET AL: "From therapeutic antibodies to chimeric antigen receptors (CARs): making better CARs based on antigen-binding domain", EXPERT OPINION ON BIOLOGICAL THERAPY, vol. 16, no. 12, 19 September 2016 (2016-09-19), ASHLEY, LONDON; GB, pages 1469 - 1478, XP055532892, ISSN: 1471-2598, DOI: 10.1080/14712598.2016.1235148 (C0)

TORIKAI ET AL.: "A foundation for universal T- cell based immunotherapy: T cells engineered to express a CD 19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR", BLOOD, vol. 119, no. 24, 14 June 2012 (2012-06-14), pages 5697 - 5705, XP055485469 (C0)